Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus ketorolac for postherpetic neuralgia
ChiCTR1900024265Phase 4Not yet recruiting
- Sponsor
- Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and ketorolac in postherpetic neuralgia (PHN) (2 arms), sponsored by Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University. Primary endpoints: T cell, Myeloid-derived suppressor cells and 1 more. Planned start Aug 2019; status: not yet recruiting.
02
Drugs
dexmedetomidineketorolac
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR1900024265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024265.